Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT04669912

COVID-19 Pandemic Lockdown Effect in Adolescents and Young Adults With Type 1 Diabetes: Positive Results of an Unpreceded Challenge for Telemedicine and Patient Self-management

Sponsor: Centre Hospitalier Sud Francilien

View on ClinicalTrials.gov

Summary

Lockdown resulting from the COVID-19 pandemic was an unpreceded model of the impact of lifestyle on chronic diseases, especially for adolescents and young adults with type 1 diabetes (T1D) whose lifestyle is known to strongly impact disease management. The investigators aimed to assess changes in self-monitoring and glycemic control in this population before, during, and after the two-month French lockdown. Te investigators hypothesized an improvement in glucose control and glucose sensor usage. The protocol will include all patients with T1D from 13 to 25 years old using a flash glucose monitoring related to the LibreView cloud platform. The primary outcome, evolution of percentage of glucose time in range 70-180 mg/dL (TIR), and secondary outcomes (glucose management indicator GMI, time spent below range TBR, and sensor usage) will be analyzed with a linear mixed-effects regression model.

Official title: Observational Study of Glycemic Control and Self-management of Young People (Aged 13 to 25 Years ) With Type 1 Diabetes During COVID-19 Lockdown.

Key Details

Gender

All

Age Range

13 Years - 25 Years

Study Type

OBSERVATIONAL

Enrollment

77

Start Date

2021-01-15

Completion Date

2021-01-22

Last Updated

2026-05-22

Healthy Volunteers

No

Conditions

Interventions

OTHER

glucose control and sensor usage

Data related to glucose control and sensor usage collected from the Libreview platform

Locations (1)

Centre Hospitalier Sud Francilien

Corbeil-Essonnes, France, France